Balaxi Pharmaceuticals Ltd 2025 Annual Report with Sustainability Disclosures
Company: Balaxi Pharmaceuticals Ltd
Sector: Manufacturing
Country: India
Year: 2025
Type: Annual Report with Sustainability Disclosures
Pages: 192
The report presents FY25 as a turnaround year, with consolidated revenue rising 21.2% to INR 292.56 crore and PAT recovering to INR 25.07 crore. The company completed construction of its first formulation plant in Jadcherla, Hyderabad, while expanding into Nicaragua and maintaining 38 warehouses. It reports a globally distributed team of over 600 professionals and includes a BRSR covering workforce, governance, human rights, and environmental disclosures. Sustainability-related risks are assigned to the Board's Risk Management Committee for oversight.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.